United States

Alchemia Ltd (ACL.AX)

ACL.AX on Australia Stock Exchange

28 Mar 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Cameron Petricevic

2019 Non-Executive Chairman of the Board

Melanie Leydin

2019 Chief Financial Officer, Company Secretary, Director

Tracey Brown

2013 Chief Scientific Officer, Vice President - Oncology

Michael West

2005 Vice President - Intellectual Property and Technology Transfer

Goslik Schepers

2009 Vice President - Business Development